Indian Medical Association (IMA) declares June 21 as ‘Vitamin D Day of India’ in collaboration with Abbott

IMT News Desk
IMT News Desk
· 2 min read
IMA declares June 21 as 'Vitamin D Day of India' with Abbott. 77% of Indians are deficient - an initiative for screening, awareness & safe sun exposure.

The Indian Medical Association (IMA), in collaboration with Abbott, has declared June 21- the longest day of the year- as ‘Vitamin D Day of India.

Nearly 77% of the population is Vitamin D-deficient in India. Modern lifestyles play a significant role- many people spend long hours indoors, use sun protection when outside, or live in urban environments where pollution limits sun exposure. Additionally, natural skin characteristics can influence how efficiently Vitamin D is produced. Low levels of this essential vitamin often go unnoticed but can have lasting effects, including weak bones, muscle pain, fatigue, and reduced immunity.

By observing June 21 as Vitamin D Day, the initiative aims to encourage healthy practices, including safe sun exposure, increased awareness, timely screening, and appropriate management where needed and prescribed by a healthcare professional. The day is also intended to serve as a long-term annual anchor for driving sustained behavior change and strengthening doctor- patient conversations.

“Declaring June 21 as Vitamin D Day is an important step in addressing a widespread yet under-recognized public health issue. As doctors, we witness the health impact of Vitamin D deficiency across age groups. This initiative will help advance awareness and encourage people to take simple, preventive actions for better health,” said Dr. Anilkumar J. Nayak, National President, IMA.

Adding to this, Dr. Jejoe Karankumar, Medical Affairs Director for Abbott in India, noted, “Vitamin D deficiency is common and often silent, yet over time it can weaken bones and affect immunity. Spending about 15- 30 minutes in sunlight between 10 am and 2 pm can help the body naturally produce Vitamin D, depending on individual factors. However, sunlight alone may not always be sufficient. Since symptoms are not always obvious, regular screening is important. If levels are low, a doctor can guide the right steps to restore and maintain healthy levels.

Read Next

India’s first focused health AI Conclave unites doctors and AI experts
Featured Article
July 10, 2026

India’s first focused health AI Conclave unites doctors and AI experts

• Global Healthcare Academy hosts HAI Conclave 2026, India’s first national platform dedicated to Healthcare and Artificial Intelligence • Landmark Bengaluru conference brings together healthcare leaders and AI experts to explore how Artificial Intelligence can make healthcare faster, safer and more accessible while keeping patients at the centre of every decision The inaugural edition of the HAI Conclave […]
Article by: IMT News Desk
Fischer Medical Ventures Highlights NYB.AI Partnership as Platform Showcased at NVIDIA GTC Taiwan 2026
News
July 10, 2026

Fischer Medical Ventures Highlights NYB.AI Partnership as Platform Showcased at NVIDIA GTC Taiwan 2026

Fischer Medical Ventures Limited (FMVL) has announced that its strategic partner, Nanyang Biologics, has achieved a major international milestone with its AI-powered molecular research platform, NYB.AI, being featured in the opening showcase at NVIDIA GTC Taiwan 2026, ahead of the keynote address by NVIDIA Founder and CEO Jensen Huang. The recognition places NYB.AI among a […]
Article by: IMT News Desk
Pharma Q1 Margins Seen Under Pressure Despite Revenue Growth: Goldman Sachs
News
July 10, 2026

Pharma Q1 Margins Seen Under Pressure Despite Revenue Growth: Goldman Sachs

Indian pharmaceutical companies are expected to report healthy revenue growth in the first quarter of FY27, but margins are likely to compress as sector profitability comes under pressure. In a recent preview note, Goldman Sachs said it anticipates around 185 basis points year-on-year margin decline for the sector in the June quarter, driven primarily by […]
Article by: IMT News Desk
Dr Reddy’s Delays Semaglutide Supplies After Active Ingredient Quality Issue
News
July 10, 2026

Dr Reddy’s Delays Semaglutide Supplies After Active Ingredient Quality Issue

Dr Reddy’s Laboratories has announced a delay in commercial supplies of its semaglutide product after certain batches were found to be out of specification due to an issue with the active pharmaceutical ingredient (API) used in the drug. The company said it has initiated an investigation into the root cause and is taking corrective measures […]
Article by: IMT News Desk